87091-29-0

Upstream product

• 849410-73-7 methyl 3-[(tert-butoxycarbonyl)amino]cyclohexanecarboxylate 
• 67-56-1 methanol 
• 16636-51-4 3-aminocyclohexanecarboxylic acid 

Downstream Products

• 87091-30-3 methyl 3-(3,4,5-trimethoxyphenylacetamido)cyclohexanecarboxylate 
• 722493-70-1 3-({5-[2-(3,4-dichloro-phenyl)-vinyl]-1H-pyrazol-3-ylmethyl}-amino)-cyclohexanecarboxylic acid methyl ester 
• 721428-25-7 4-(tert-butyl-diphenyl-silanyloxy)-3-[(3-methoxycarbonyl-cyclohexylamino)-methyl]-indazole-1-carboxylic acid tert-butyl ester 
• 1383797-27-0 methyl 3-(diphenylmethyleneamino)cyclohexanecarboxylate 
• 1383797-31-6 methyl 3-amino-1-(4-fluorobenzyl)cyclohexanecarboxylate 
• 1383797-29-2 methyl 3-(diphenylmethyleneamino)-1-(4-fluorobenzyl)cyclohexanecarboxylate 
• 87091-31-4 methyl 3-(3,4,5-trimethoxyphenethylamino)cyclohexanecarboxylate 
• 87091-37-0 6-(3,4,5-trimethoxyphenethyl)-6-azabicyclo<3.2.1>octan-7-one 
• 203720-98-3 3-[(7-Nitro-2,3-dioxo-1,2,3,4-tetrahydro-quinoxalin-5-ylmethyl)-amino]-cyclohexanecarboxylic acid methyl ester 

Relevant academic research and scientific papers

INDAZOLE DERIVATIVES USEFUL AS ERK INHIBITORS

The present invention provides a compound of the Formula I, or a pharmaceutically acceptable salt, solvate or ester thereof, wherein R, R1, R2, R3, m and are as defined herein. The compounds are ERK inhibitors. Also disclosed are pharmaceutical compositions that comprise the above compounds, and methods of treating cancer using the same.

TETRAPEPTIDE INHIBITORS OF BETA-SECRETASE

Statine-derived peptide inhibitors of the β-secretase enzyme are provided which are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of Aβ peptide in a mammal. The compounds of the invention provide useful meth